Literature DB >> 33597779

COVID vaccines and safety: what the research says.

Ariana Remmel.   

Abstract

Entities:  

Keywords:  Chemistry; Health care; Immunology; Public health; SARS-CoV-2; Vaccines

Mesh：

Substances：

Year:  2021        PMID： 33597779     DOI： 10.1038/d41586-021-00290-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  2 in total

1.  Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population.

Authors:  Qi Yang; Timothy M Jacobs; Justin D McCallen; Dominic T Moore; Justin T Huckaby; Jasmine N Edelstein; Samuel K Lai
Journal:  Anal Chem       Date:  2016-11-16       Impact factor: 6.986

2.  Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.

Authors:  Denis Y Logunov; Inna V Dolzhikova; Dmitry V Shcheblyakov
Journal:  Lancet       Date:  2021-05-12       Impact factor: 79.321
  2 in total
  23 in total

1.  Non-life-threatening adverse reactions from COVID-19 vaccine; a cross-sectional study with self-reported symptoms among Ghanaian healthcare workers.

Authors:  Dorcas Serwaa; Felix Osei-Boakye; Charles Nkansah; Selasie Ahiatrogah; Emmanuel Lamptey; Ratif Abdulai; Maxwell Hubert Antwi; Eric Yaw Wirekoh; Ernest Owusu; Tonnies Abeku Buckman; Mark Danquah
Journal:  Hum Vaccin Immunother       Date:  2021-09-21       Impact factor: 4.526

Review 2.  Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment.

Authors:  Abdel-Majed Safer; Stefano Leporatti
Journal:  Int J Nanomedicine       Date:  2021-12-16

3.  COVID-19 vaccine side effects: The positives about feeling bad.

Authors:  Jonathan Sprent; Cecile King
Journal:  Sci Immunol       Date:  2021-06-22

4.  Decreasing transmission and initiation of countrywide vaccination: Key challenges for future management of COVID-19 pandemic in Bangladesh.

Authors:  Md Maruf Ahmed Molla; Jannat Ara Disha; Mahmuda Yeasmin; Asish Kumar Ghosh; Tasnim Nafisa
Journal:  Int J Health Plann Manage       Date:  2021-03-25

5.  SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Authors:  Tara M Narowski; Kristin Raphel; Lily E Adams; Jenny Huang; Nadja A Vielot; Ramesh Jadi; Aravinda M de Silva; Ralph S Baric; John E Lafleur; Lakshmanane Premkumar
Journal:  Cell Rep       Date:  2022-01-20       Impact factor: 9.995

6.  Fair and diverse allocation of scarce resources.

Authors:  Hadis Anahideh; Lulu Kang; Nazanin Nezami
Journal:  Socioecon Plann Sci       Date:  2021-11-13       Impact factor: 4.923

7.  COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey.

Authors:  Robert Kaba Alhassan; Matilda Aberese-Ako; Phidelia Theresa Doegah; Mustapha Immurana; Maxwel Ayindenaba Dalaba; Alfred Kwesi Manyeh; Desmond Klu; Evelyn Acquah; Evelyn Korkor Ansah; Margaret Gyapong
Journal:  Trop Med Health       Date:  2021-12-16

Review 8.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

9.  A Comparison of Vaccine Hesitancy of COVID-19 Vaccination in China and the United States.

Authors:  Taoran Liu; Zonglin He; Jian Huang; Ni Yan; Qian Chen; Fengqiu Huang; Yuejia Zhang; Omolola M Akinwunmi; Babatunde O Akinwunmi; Casper J P Zhang; Yibo Wu; Wai-Kit Ming
Journal:  Vaccines (Basel)       Date:  2021-06-14

10.  Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V).

Authors:  Arvind Nune; Karthikeyan P Iyengar; Christopher Goddard; Ashar E Ahmed
Journal:  BMJ Case Rep       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.